Open original FDA record ↗Recall record
- FDA identifier
- Z-2327-2026
- Company in FDA record
- INSPIREMD Inc
- FDA classification date
- Jun 5, 2026
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Stent delivery system may encounter complications during deployment which may result in high resistance or inability to deploy the stent.
Source facts
- Action
- On May 1, 2026, InspireMD, Inc. issued a Urgent Medical Device Recall notification to affected consignees. InspireMD asked consignees to take the following actions: 1. Cease further use of all affected CGuard Prime Carotid Stent Systems identified by the model numbers listed in the letter. 2. Quarantine and segregate all affected units currently in your inventory. Place affected product in a clearly labeled quarantine area to prevent inadvertent use. 3. This notice needs to be passed on to all those who need to be aware within your organization or facilities where the affected devices have been transferred. 4. Please retain a copy of this letter, and keep a copy of the Acknowledgement Form. 5. Complete the attached Acknowledgement Form and return it by email to USSupport@inspiremd.com within 2 business days. 6. InspireMD will contact each affected customer to facilitate the return and disposition process.
- Initiated
- 2026-05-01
- Root cause
- Component design/selection
- Distribution
- US Nationwide distribution in the states of AR, AZ, CA, DC, FL, GA, HI, IL, IN, KS, MA, MD, MI, MO, NC, NJ, NV, NY, OH, OR, RI, SD, TN, TX, VA, WA, WI, WV.
- Recall number
- Z-2327-2026
- Recall status
- Open, Classified
- CDRH record ID
- 220208
- FDA classified
- 2026-06-05
- Recall event number
- 98922